Humacyte (HUMA) EPS (Weighted Average and Diluted) Growth (1y) (2021 - 2026)
Humacyte (HUMA) EPS (Weighted Average and Diluted) Growth (1y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EPS (Weighted Avg. Diluted) Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
251.11% |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
-13.31% |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
102.51% |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
-79.34% |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
- |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
-103.05% |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
61.45% |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
- |
| 10 |
Humacyte |
267.09 Mn |
218.55 Mn |
-1.54 Mn |
-132.14% |
| Date | Value |
|---|
| Mar 31, 2026 |
-132.14% |
| Dec 31, 2025 |
6.25% |
| Sep 30, 2025 |
66.67% |
| Jun 30, 2025 |
50.00% |
| Mar 31, 2025 |
196.55% |
| Dec 31, 2024 |
33.33% |
| Sep 30, 2024 |
-32.00% |
| Jun 30, 2024 |
-118.18% |
| Mar 31, 2024 |
19.44% |
| Dec 31, 2023 |
-500.00% |
| Sep 30, 2023 |
0.00% |
| Jun 30, 2023 |
-162.86% |
| Mar 31, 2023 |
-89.47% |
| Dec 31, 2022 |
-101.32% |
| Sep 30, 2022 |
65.28% |
| Jun 30, 2022 |
112.11% |
| Mar 31, 2022 |
94.51% |
| Dec 31, 2021 |
208.21% |
| Sep 30, 2021 |
76.55% |
